Enrico Benedetti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Enrico Benedetti has a total of 393 co-authors. Here are the top co-authors by number of shared publications:
- Ivo Tzvetanov
Department of Surgery, University of Illinois Chicago College of Medicine, Chicago, USA
19 shared publications Giuliano Testa
Division of Transplantation, University of Chicago Medical Center, Chicago, IL, USA
18 shared publicationsHoward Sankary
13 shared publicationsDiego Bogetti
12 shared publicationsJose Oberholzer
Univ Virginia, Dept Surg, Charlottesville, VA USA
11 shared publicationsFabrizio Panaro
Department of Surgery, Division of Transplantation, University of Illinois at Chicago, Chicago, IL, USA
8 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 1214
Anesthetic outcomes in robotic kidney transplantation: a retrospective cohort analysis
Kidney transplantation is the definitive treatment for end-stage renal disease. Within the last decade, robotic-assisted kidney transplants have emerged as a promising alternative to the traditional open approach, but the impact on postoperative pain is unclear. We conducted a propensity-matched retrospective study to investigate postoperative pain control between open and robotic kidney transplant in adults at the University of Illinois Hospital from September 2020 to September 2025. The primary outcome was opioid consumption within 30 days after surgery. Secondary outcomes included the highest pain score within 72 hours of surgery, intraoperative opioid consumption, length of stay, and total hospital length of stay. Of 1379 patients, significant differences in baseline characteristics were observed between the open ( n = 1234) and robotic ( n = 145) approaches for age, weight and BMI. Propensity matching resulted in 127 pairs with no significant difference in opioid consumption within 30 days of surgery, intraoperative milligram morphine equivalents, highest pain score in recovery within 72 hours, and length of stay. Robotic cases were longer with less blood loss and required a smaller volume of packed red blood cell transfusions. Multivariate linear regression of 30-day morphine equivalents demonstrated a reduction in patients who were immediately extubated following completion of surgery. Robotic transplants resulted in similar postoperative opioid consumption and pain scores to open transplants but were longer and less bloody. Prolonged intubation after surgery contributed to opioid use. Our results contradict prior literature, which has reported reduced pain and opioid use with robotic approaches.
- 13 November 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 1214
Open AccessAnesthetic outcomes in robotic kidney transplantation: a retrospective cohort analysis
Kidney transplantation is the definitive treatment for end-stage renal disease. Within the last decade, robotic-assisted kidney transplants have emerged as a promising alternative to the traditional open approach, but the impact on postoperative pain is unclear. We conducted a propensity-matched retrospective study to investigate postoperative pain control between open and robotic kidney transplant in adults at the University of Illinois Hospital from September 2020 to September 2025. The primary outcome was opioid consumption within 30 days after surgery. Secondary outcomes included the highest pain score within 72 hours of surgery, intraoperative opioid consumption, length of stay, and total hospital length of stay. Of 1379 patients, significant differences in baseline characteristics were observed between the open ( n = 1234) and robotic ( n = 145) approaches for age, weight and BMI. Propensity matching resulted in 127 pairs with no significant difference in opioid consumption within 30 days of surgery, intraoperative milligram morphine equivalents, highest pain score in recovery within 72 hours, and length of stay. Robotic cases were longer with less blood loss and required a smaller volume of packed red blood cell transfusions. Multivariate linear regression of 30-day morphine equivalents demonstrated a reduction in patients who were immediately extubated following completion of surgery. Robotic transplants resulted in similar postoperative opioid consumption and pain scores to open transplants but were longer and less bloody. Prolonged intubation after surgery contributed to opioid use. Our results contradict prior literature, which has reported reduced pain and opioid use with robotic approaches.
- Open Access
- 19 August 2026
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 284 (4) , 709-716
Tele-Robotic Surgery for Combat Casualty Care
Objective: These experiments test the feasibility of tele-robotic surgery for the shipboard care of combat casualties. Summary Background Data: Limited research on the effects of telecommunications latency on tele-robotics has been a consistent concern in the growth of tele-robotic surgery. These experiments are designed to provide well-controlled real-world data on robotic surgical performance with electronically added latency that simulates combat-relevant, satellite-based tele-robotic communication. Methods: Surgeons at 2 university hospitals separated by 1096 km bi-directionally performed remote cholecystectomy (Ch) and right colectomy (Co) dissections on cadaver subjects. Varying latency between 0 and 300 ms was electronically added. Network performance, OR time, Global Performance (GP), and Surgery Task Load Index (TLX) were determined. Statistical analysis: simple linear regression. Results: Network latency was 28 ms, jitter 0.03 ms, with zero packet loss. Including robotic intrinsic latency of 50 ms, total latency (TOT) varied from 78 to 378 ms. 12 Ch and 14 Co were performed by 4 surgeons. Co OR time unexpectedly decreased with TOT ( P =0.005), but Ch did not ( P =0.47). OR time was strongly associated with general surgeon experience ( P =0.024). TLX was strongly associated with surgeon experience ( P P =0.47). GP was consistently between 4/5 and 5/5 across all domains and did not correlate with TOT ( P =0.41). Each surgeon showed rapid cognitive and motor adaptation to increasing latency. Conclusions: Experienced robotic surgeons rapidly develop cognitive and motor adaptation to tele-robotic latency. Satellite-based tele-robotic surgery in combat environments may add greater latency than fiber-optic-connected civilian applications. Our data indicate a significantly greater tolerance for latency than previously reported. Development of telerobotic surgery for combat casualties is highly feasible.
- 19 August 2026
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 284 (4) , 709-716
Open AccessTele-Robotic Surgery for Combat Casualty Care
Objective: These experiments test the feasibility of tele-robotic surgery for the shipboard care of combat casualties. Summary Background Data: Limited research on the effects of telecommunications latency on tele-robotics has been a consistent concern in the growth of tele-robotic surgery. These experiments are designed to provide well-controlled real-world data on robotic surgical performance with electronically added latency that simulates combat-relevant, satellite-based tele-robotic communication. Methods: Surgeons at 2 university hospitals separated by 1096 km bi-directionally performed remote cholecystectomy (Ch) and right colectomy (Co) dissections on cadaver subjects. Varying latency between 0 and 300 ms was electronically added. Network performance, OR time, Global Performance (GP), and Surgery Task Load Index (TLX) were determined. Statistical analysis: simple linear regression. Results: Network latency was 28 ms, jitter 0.03 ms, with zero packet loss. Including robotic intrinsic latency of 50 ms, total latency (TOT) varied from 78 to 378 ms. 12 Ch and 14 Co were performed by 4 surgeons. Co OR time unexpectedly decreased with TOT ( P =0.005), but Ch did not ( P =0.47). OR time was strongly associated with general surgeon experience ( P =0.024). TLX was strongly associated with surgeon experience ( P P =0.47). GP was consistently between 4/5 and 5/5 across all domains and did not correlate with TOT ( P =0.41). Each surgeon showed rapid cognitive and motor adaptation to increasing latency. Conclusions: Experienced robotic surgeons rapidly develop cognitive and motor adaptation to tele-robotic latency. Satellite-based tele-robotic surgery in combat environments may add greater latency than fiber-optic-connected civilian applications. Our data indicate a significantly greater tolerance for latency than previously reported. Development of telerobotic surgery for combat casualties is highly feasible.
- 9 March 2026
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 55 (2) , 275-286
Combined Liver–Small Bowel Transplant in Children
- 9 March 2026
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 55 (2) , 275-286
Combined Liver–Small Bowel Transplant in Children
- Open Access
- 17 December 2025
- Published by Elsevier in Human Immunology
- Vol. 87 (2) , 111637
Increasing the liver donation pool: Eculizumab desensitization for ABO-incompatible living donor liver transplantation – A case series
- 17 December 2025
- Published by Elsevier in Human Immunology
- Vol. 87 (2) , 111637
Open AccessIncreasing the liver donation pool: Eculizumab desensitization for ABO-incompatible living donor liver transplantation – A case series
- Open Access
- 24 July 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (8) , 1819
Comparison of Angiotensin II (Giapreza®) Use in Kidney Transplantation Between Black and Non-Black Patients
Background/Objectives: Perioperative hypotension during kidney transplantation poses a risk to graft function and survival. Angiotensin II (AngII) is an endogenous vasoconstrictor targeting the renin–angiotensin–aldosterone system (RAAS) to increase blood pressure. Black patients may have a different response to synthetic angiotensin II (AT2S) compared to non-Black patients, given differential expressions in renin profiles. The purpose of this study is to assess the difference between Black and non-Black patients in total vasopressor duration and usage when AT2S is first line for hypotension during kidney transplantation. Methods: A single-center, retrospective cohort study comparing Black and non-Black patients who required AT2S as a first-line vasopressor for hypotension during the perioperative period of kidney transplantation. Results: The primary outcome evaluating total usage of vasopressors found that Black patients required longer durations of vasopressors (36.9 ± 66.8 h vs. 23.7 ± 31.7 h; p = 0.022) but no difference in vasopressor amount (0.07 ± 0.1 NEE vs. 0.05 ± 0.1 NEE; p = 0.128) compared to non-Black patients. Regression analysis found that body weight was associated with the duration of vasopressors (p < 0.05), while baseline systolic blood pressure was inversely associated with it. Longer duration of vasopressors and duration of transplant surgery were associated with delayed graft function in regression analysis (p < 0.05). Conclusions: Black patients had a longer duration of vasopressors, but this was not driven by differences in usage of AT2S. As baseline weight was significantly higher in Black patients and associated with duration of usage, perhaps the metabolic differences in our Black patients led to the observed differences. Regardless, longer durations of vasopressors were associated with delayed graft function, making this an area of utmost importance for continued investigation.
- 24 July 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (8) , 1819
Open AccessComparison of Angiotensin II (Giapreza®) Use in Kidney Transplantation Between Black and Non-Black Patients
Background/Objectives: Perioperative hypotension during kidney transplantation poses a risk to graft function and survival. Angiotensin II (AngII) is an endogenous vasoconstrictor targeting the renin–angiotensin–aldosterone system (RAAS) to increase blood pressure. Black patients may have a different response to synthetic angiotensin II (AT2S) compared to non-Black patients, given differential expressions in renin profiles. The purpose of this study is to assess the difference between Black and non-Black patients in total vasopressor duration and usage when AT2S is first line for hypotension during kidney transplantation. Methods: A single-center, retrospective cohort study comparing Black and non-Black patients who required AT2S as a first-line vasopressor for hypotension during the perioperative period of kidney transplantation. Results: The primary outcome evaluating total usage of vasopressors found that Black patients required longer durations of vasopressors (36.9 ± 66.8 h vs. 23.7 ± 31.7 h; p = 0.022) but no difference in vasopressor amount (0.07 ± 0.1 NEE vs. 0.05 ± 0.1 NEE; p = 0.128) compared to non-Black patients. Regression analysis found that body weight was associated with the duration of vasopressors (p < 0.05), while baseline systolic blood pressure was inversely associated with it. Longer duration of vasopressors and duration of transplant surgery were associated with delayed graft function in regression analysis (p < 0.05). Conclusions: Black patients had a longer duration of vasopressors, but this was not driven by differences in usage of AT2S. As baseline weight was significantly higher in Black patients and associated with duration of usage, perhaps the metabolic differences in our Black patients led to the observed differences. Regardless, longer durations of vasopressors were associated with delayed graft function, making this an area of utmost importance for continued investigation.
- Open Access
- 20 June 2025
- Published by Wolters Kluwer Health in Annals of Surgery
Recommendations from the 2024 Minimally Invasive Organ Transplant Consensus Conference – MIOT.CC
Objectives: The Minimally Invasive Organ Transplant Consensus Conference (MIOT.CC) aimed to develop evidence-based recommendations for advancing minimally invasive techniques in organ transplantation. Background: Minimally invasive approaches (laparoscopic/robotic) are underutilized in transplantation compared to other specialties, despite potential advantages such as reduced morbidity and faster recovery. Methods: The conference Held in Riyadh, Saudi Arabia (December 2024) included international experts in minimally invasive donation and/or transplantation of the kidney, liver, pancreas, lung, heart, and uterus. Using the Danish Model of Consensus, participants reviewed current practice and evidence to formulate recommendations. The process included systematic literature reviews according to PRISMA guidelines and assessment of evidence quality using the GRADE approach. Results: Minimally invasive approaches consistently reduced postoperative pain, complications, and hospital stay. Specific recommendations were derived for each organ, with particular attention to donor safety and to the expansion of robotic techniques, if appropriately supported by locally available technology and experience. Conclusion: MIOT.CC delineated a framework to disseminate minimally invasive techniques in both organ donation and transplantation. These recommendations can guide centers worldwide to first implement and subsequently optimize minimally invasive approaches through ongoing evaluation and adaptation based on emerging evidence and technological advancements.
- 20 June 2025
- Published by Wolters Kluwer Health in Annals of Surgery
Open AccessRecommendations from the 2024 Minimally Invasive Organ Transplant Consensus Conference – MIOT.CC
Objectives: The Minimally Invasive Organ Transplant Consensus Conference (MIOT.CC) aimed to develop evidence-based recommendations for advancing minimally invasive techniques in organ transplantation. Background: Minimally invasive approaches (laparoscopic/robotic) are underutilized in transplantation compared to other specialties, despite potential advantages such as reduced morbidity and faster recovery. Methods: The conference Held in Riyadh, Saudi Arabia (December 2024) included international experts in minimally invasive donation and/or transplantation of the kidney, liver, pancreas, lung, heart, and uterus. Using the Danish Model of Consensus, participants reviewed current practice and evidence to formulate recommendations. The process included systematic literature reviews according to PRISMA guidelines and assessment of evidence quality using the GRADE approach. Results: Minimally invasive approaches consistently reduced postoperative pain, complications, and hospital stay. Specific recommendations were derived for each organ, with particular attention to donor safety and to the expansion of robotic techniques, if appropriately supported by locally available technology and experience. Conclusion: MIOT.CC delineated a framework to disseminate minimally invasive techniques in both organ donation and transplantation. These recommendations can guide centers worldwide to first implement and subsequently optimize minimally invasive approaches through ongoing evaluation and adaptation based on emerging evidence and technological advancements.
- Open Access
- 21 August 2024
- Published by Wiley in Clinical Transplantation
- Vol. 38 (8) , e15432
Efficacy and Safety of Perioperative Angiotensin II Versus Phenylephrine as a First‐Line Continuous Infusion Vasopressor in Kidney Transplant Recipients
Introduction: Angiotensin II (ATII) maintains blood pressure via RAAS with a beneficial adverse effect profile versus catecholamines and phenylephrine. Head‐to‐head data comparing ATII to phenylephrine are lacking regarding renal allograft function, hemodynamic efficacy, and safety within the perioperative period of kidney transplantation.Methods: This single‐center, retrospective study included adult kidney transplant recipients who received continuous infusions of ATII or phenylephrine within a 24‐h perioperative period as a first‐line vasopressor according to an institutional algorithm. The primary endpoint was allograft function. Secondary endpoints were hemodynamic efficacy and adverse effects.Results: Among 105 patients, there was no significant difference in IGF (p = 0.545), SGF (p = 0.557), or DGF (p = 0.878) between patient cohorts. In the 34 patients with cold ischemia time (CIT) > 14‐h, IGF was higher (p = 0.013) and DGF (p = 0.045) was lower in the ATII cohort versus phenylephrine. In all patients, ATII was associated with a decreased need for additional vasopressor agents (p < 0.001). Adverse effect profiles were similar between cohorts (p > 0.05).Conclusion: Among kidney transplant recipients, ATII may be a suitable first‐line alternative compared with phenylephrine in the perioperative period for hypotension management with a reduced need for additional vasopressor support. Allograft benefits were observed in patients with prolonged CIT.
- 21 August 2024
- Published by Wiley in Clinical Transplantation
- Vol. 38 (8) , e15432
Open AccessEfficacy and Safety of Perioperative Angiotensin II Versus Phenylephrine as a First‐Line Continuous Infusion Vasopressor in Kidney Transplant Recipients
Introduction: Angiotensin II (ATII) maintains blood pressure via RAAS with a beneficial adverse effect profile versus catecholamines and phenylephrine. Head‐to‐head data comparing ATII to phenylephrine are lacking regarding renal allograft function, hemodynamic efficacy, and safety within the perioperative period of kidney transplantation.Methods: This single‐center, retrospective study included adult kidney transplant recipients who received continuous infusions of ATII or phenylephrine within a 24‐h perioperative period as a first‐line vasopressor according to an institutional algorithm. The primary endpoint was allograft function. Secondary endpoints were hemodynamic efficacy and adverse effects.Results: Among 105 patients, there was no significant difference in IGF (p = 0.545), SGF (p = 0.557), or DGF (p = 0.878) between patient cohorts. In the 34 patients with cold ischemia time (CIT) > 14‐h, IGF was higher (p = 0.013) and DGF (p = 0.045) was lower in the ATII cohort versus phenylephrine. In all patients, ATII was associated with a decreased need for additional vasopressor agents (p < 0.001). Adverse effect profiles were similar between cohorts (p > 0.05).Conclusion: Among kidney transplant recipients, ATII may be a suitable first‐line alternative compared with phenylephrine in the perioperative period for hypotension management with a reduced need for additional vasopressor support. Allograft benefits were observed in patients with prolonged CIT.
- Open Access
- 8 August 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (9) , e1671
Analyzing the Impact of CIT on the Largest Reported Cohort of Robotic Kidney Transplantation From the Deceased Donors
Background.: Robotic-assisted kidney transplant (RAKT) has proven to be a successful approach for patients with morbid obesity and more centers are encouraged to apply robotic approach also for deceased donor kidney transplantation. Prolonged cold ischemia time (CIT) is accompanied by delayed graft function (DGF) and early graft loss after traditional open kidney transplant (OKT). This study examines the impact of CIT after robotic kidney transplantation on settings of deceased donation. Methods.: We present a single-center retrospective analysis of 115 cases of RAKT and 128 cases of OKT from deceased donors performed from deceased donor from 2009 to July 2022. Cohort was divided in 3 groups based on CIT (“high” CIT > 15 h, n = 43; “medium” CIT 11–15 h, n = 38; “low” CIT< 11 h, n = 40). The subgroup analysis of DGF and CIT was performed. Results.: The median CIT in the cohort was 13.46 (7) h, and overall rate of DGF was 30.6%. The correlation between CIT and DGF was statistically significant (P = 0.008), and DGF negatively correlated with 1-y graft survival (P = 0.04). The rate of DGF was significantly different between the groups (P = 0.05). Conclusions.: Results from our study demonstrate that the effect of CIT on DGF in settings of RAKT follows a similar pattern as in traditional OKT.
- 8 August 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (9) , e1671
Open AccessAnalyzing the Impact of CIT on the Largest Reported Cohort of Robotic Kidney Transplantation From the Deceased Donors
Background.: Robotic-assisted kidney transplant (RAKT) has proven to be a successful approach for patients with morbid obesity and more centers are encouraged to apply robotic approach also for deceased donor kidney transplantation. Prolonged cold ischemia time (CIT) is accompanied by delayed graft function (DGF) and early graft loss after traditional open kidney transplant (OKT). This study examines the impact of CIT after robotic kidney transplantation on settings of deceased donation. Methods.: We present a single-center retrospective analysis of 115 cases of RAKT and 128 cases of OKT from deceased donors performed from deceased donor from 2009 to July 2022. Cohort was divided in 3 groups based on CIT (“high” CIT > 15 h, n = 43; “medium” CIT 11–15 h, n = 38; “low” CIT< 11 h, n = 40). The subgroup analysis of DGF and CIT was performed. Results.: The median CIT in the cohort was 13.46 (7) h, and overall rate of DGF was 30.6%. The correlation between CIT and DGF was statistically significant (P = 0.008), and DGF negatively correlated with 1-y graft survival (P = 0.04). The rate of DGF was significantly different between the groups (P = 0.05). Conclusions.: Results from our study demonstrate that the effect of CIT on DGF in settings of RAKT follows a similar pattern as in traditional OKT.
- Open Access
- 28 December 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (6) , 1035-1045
Single-center retrospective assessment of robotic-assisted simultaneous pancreas-kidney transplants: Exploring clinical utility
- 28 December 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (6) , 1035-1045
Open AccessSingle-center retrospective assessment of robotic-assisted simultaneous pancreas-kidney transplants: Exploring clinical utility
- Open Access
- 23 September 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (12) , 1980-1989
Characterizing the risk of human leukocyte antigen-incompatible living donor kidney transplantation in older recipients
- 23 September 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (12) , 1980-1989
Open AccessCharacterizing the risk of human leukocyte antigen-incompatible living donor kidney transplantation in older recipients